TCL Archive Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year. March 2, 2001
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
